WIPI2 (N-term), 4-32 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-WIPI2 (N-term), 4-32 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | WIPI2 (N-term), 4-32 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.5 |
| Applications | Western Blot (WB), ELISA (EIA), Immunohistochemistry (IHC) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This WIPI2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 4-32 amino acids from the N-terminal region of human WIPI2. WD40 repeat proteins are key components of many essentialbiologic functions. They regulate the assembly of multiproteincomplexes by presenting a beta-propeller platform for simultaneousand reversible protein-protein interactions. Members of the WIPIsubfamily of WD40 repeat proteins, such as WIPI2, have a 7-bladedpropeller structure and contain a conserved motif for interactionwith phospholipids (Proikas-Cezanne et al., 2004 [PubMed15602573]). |
| Immunogen | n/a |
| Other Names | [WD repeat domain phosphoinositide-interacting protein 2; WIPI-2; WIPI49-like protein 2; WIPI2] |
| Gene, Accession # | [WIPI2], Gene ID: 26100, NCBI: NP_001028690.1, UniProt: Q9Y4P8 |
| Catalog # | MBS9201874 |
| Price | $165, $370 |
| Order / More Info | WIPI2 (N-term), 4-32 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Sugiyama, N., et al. Mol. Cell Proteomics 6(6):1103-1109(2007) Proikas-Cezanne, T., et al. Oncogene 23(58):9314-9325(2004) Simpson, J.C., et al. EMBO Rep. 1(3):287-292(2000) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies